Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Agnosia × Electroacupuncture × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 3 Pain 3 Neoplasms 3 Sleep Initiation and Maintenance Disorders 2 Polycystic Ovary Syndrome 2 Osteosarcoma 2 Head and Neck Neoplasms 2 Depression 2 Colorectal Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Breast Neoplasms 2 Anxiety Disorders 2 Acupuncture 2 Xerostomia 1 Vomiting 1 Urinary Incontinence, Stress 1 Urinary Incontinence 1 Testicular Neoplasms 1 Teratoma 1 Sarcoma, Ewing 1 Sarcoma 1 Salivary Gland Neoplasms 1 Radiation Injuries 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Postoperative Ileus 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Ovarian Germ Cell Cancer 1 Oropharyngeal Neoplasms 1 Opioid-Induced Constipation 1

Interventions

Anesthesia, General 5 Dexmedetomidine 4 Bupivacaine 4 Anesthesia, Local 4 Acupuncture Therapy 4 parecoxib 2 Transcutaneous Electric Nerve Stimulation 2 Saline Solution 2 Ropivacaine 2 Radiofrequency Ablation 2 Pregabalin 2 Morphine 2 Fentanyl 2 Ethanol 2 Dental Occlusion 2 Control Groups 2 Anesthetics, Local 2 Anesthesia, Conduction 2 Analgesics, Opioid 2 loxoprofen 1 engage 8200 1 Yoga 1 Uterine Myomectomy 1 Transcranial Direct Current Stimulation 1 Tramadol 1 Touch 1 Telemedicine 1 Surgical Instruments 1 Standard of Care 1 Sodium Chloride 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04917796 2026-01-30

ACT

Dana-Farber Cancer Institute

Phase NA Active not recruiting

Neuropathy, Painful, Agnosia, Neuralgia, Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡